Jiuyang Zhao

This inventor holds 9 USPTO granted patents and 1 published patent application and 6 EPO patents. Top assignee: Shenzhen Targetrx, Inc.. Active years: 2020-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jiuyang Zhao. Retrieved from https://idiyas.com/inventor/jiuyang-zhao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 1)

% Patents Active = 100.0

EPO Patents = 6 (Patent Applications = 12)

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 8(Granted Patents)

Location History:

Guangdong, CN (2020 - 2022)
Shenzhen, CN (2021 - 2022)

Company Filing History:

9 out of 37

Shenzhen Targetrx, Inc.

patents

Years Active: 2020-2022

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11453672 - Substituted pyrazolo[1,5-a]pyrimidines as tropomyosin receptor kinase inhibitors (2022-09-27),

2. 11447512 - Antiviral nucleoside reverse transcriptase inhibitor (2022-09-20),

3. 11389463 - Antiviral nucleoside reverse transcriptase inhibitor (2022-07-19),

4. 11358973 - Di(hetero)aryl macrocyclic compound for inhibiting protein kinase activity (2022-06-14),

5. 11345703 - Substituted pyrazolo[1,5-a]pyrimidine macrocyclic compound (2022-05-31),

6. 11319317 - (Hetero)arylamide compound for inhibiting protein kinase activity (2022-05-03),

7. 11091462 - (Hetero)arylamide compound for inhibiting protein kinase activity (2021-08-17),

8. 10995103 - Substituted boric acid compound, pharmaceutical composition comprising same, and application thereof (2021-05-04),

9. 10875853 - (Hetero)arylamide compound for inhibiting protein kinase activity (2020-12-29),

Title: The Innovative Contributions of Jiuyang Zhao

Introduction

Jiuyang Zhao is a prominent inventor based in Guangdong, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various diseases. With a total of 9 patents to his name, Zhao's work is recognized for its potential impact on medical treatments.

Latest Patents

Among his latest patents, Zhao has developed substituted pyrazolo[1,5-a]pyrimidines as tropomyosin receptor kinase inhibitors. This patent provides pharmaceutical compositions that include these compounds, which can be used to treat diseases that are responsive to Trk kinase inhibitors. Another notable patent is for an antiviral nucleoside reverse transcriptase inhibitor, which is designed to combat viral infectious diseases such as HIV and hepatitis B. This compound, along with its various forms, showcases Zhao's commitment to advancing antiviral therapies.

Career Highlights

Zhao is currently associated with Shenzhen Targetrx, Inc., where he continues to innovate and develop new pharmaceutical solutions. His work has garnered attention in the scientific community, and he is recognized for his contributions to drug development.

Collaborations

Zhao collaborates with talented individuals in his field, including Yihan Wang and Yixin Ai. These partnerships enhance the research and development process, leading to more effective pharmaceutical innovations.

Conclusion

Jiuyang Zhao's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a key inventor in the industry. His work not only advances medical science but also offers hope for effective treatments for various diseases.

Profile summary based on public USPTO records.